Jack Nathan Medical Corp. (TSXV:JNH)
Canada
· Delayed Price · Currency is CAD 0.0100
+0.0050 (100.00%)
May 12, 2025, 9:30 AM EDT
Jack Nathan Medical Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 |
| Revenue | 21.33 | 19.14 | 15.49 | 9.64 | 3.85 | 3.62 | Upgrade
|
| Revenue Growth (YoY) | 22.43% | 23.61% | 60.68% | 150.21% | 6.50% | 23.66% | Upgrade
|
| Cost of Revenue | 4.71 | 4.67 | 3.04 | 2.98 | 0.8 | 0.84 | Upgrade
|
| Gross Profit | 16.62 | 14.48 | 12.44 | 6.66 | 3.05 | 2.78 | Upgrade
|
| Selling, General & Admin | 22.09 | 17.85 | 15.45 | 9.67 | 2.77 | 2.54 | Upgrade
|
| Research & Development | - | - | - | 0.55 | 0.1 | - | Upgrade
|
| Operating Expenses | 23.57 | 19.68 | 17.64 | 13.2 | 3.86 | 2.65 | Upgrade
|
| Operating Income | -6.95 | -5.2 | -5.2 | -6.55 | -0.81 | 0.13 | Upgrade
|
| Interest Expense | -2.24 | -1.31 | -0.41 | -0.18 | -0.04 | -0.17 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.07 | 0.01 | 0.04 | 0.02 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.12 | 0.14 | 0.21 | -0.05 | -0.08 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | -0.08 | -0.14 | -0.36 | -0.07 | - | Upgrade
|
| EBT Excluding Unusual Items | -9.18 | -6.38 | -5.53 | -7.11 | -0.97 | -0.02 | Upgrade
|
| Merger & Restructuring Charges | - | -1.12 | -0.25 | -0.6 | -0.1 | - | Upgrade
|
| Impairment of Goodwill | - | - | -1.01 | -0.96 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.59 | -1.39 | Upgrade
|
| Asset Writedown | - | - | -0.4 | - | - | - | Upgrade
|
| Other Unusual Items | 0.06 | 0.06 | 0.2 | 0.43 | -8.63 | 0.03 | Upgrade
|
| Pretax Income | -9.12 | -7.44 | -6.99 | -8.23 | -10.29 | -1.38 | Upgrade
|
| Income Tax Expense | -0.7 | -0.81 | -0.09 | -0.22 | -0.38 | -0.02 | Upgrade
|
| Earnings From Continuing Operations | -8.42 | -6.64 | -6.9 | -8.02 | -9.91 | -1.36 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.21 | 0.01 | - | Upgrade
|
| Net Income | -8.42 | -6.64 | -6.9 | -7.81 | -9.9 | -1.36 | Upgrade
|
| Net Income to Common | -8.42 | -6.64 | -6.9 | -7.81 | -9.9 | -1.36 | Upgrade
|
| Shares Outstanding (Basic) | 87 | 86 | 84 | 82 | 52 | 44 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 86 | 84 | 82 | 52 | 44 | Upgrade
|
| Shares Change (YoY) | 2.37% | 1.47% | 2.51% | 59.28% | 16.28% | 1232.00% | Upgrade
|
| EPS (Basic) | -0.10 | -0.08 | -0.08 | -0.09 | -0.19 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.10 | -0.08 | -0.08 | -0.10 | -0.19 | -0.03 | Upgrade
|
| Free Cash Flow | -9 | -10.2 | -4.59 | -5.29 | -1.31 | -0.63 | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.12 | -0.05 | -0.06 | -0.03 | -0.01 | Upgrade
|
| Gross Margin | 77.93% | 75.62% | 80.34% | 69.05% | 79.19% | 76.74% | Upgrade
|
| Operating Margin | -32.58% | -27.16% | -33.57% | -67.95% | -20.91% | 3.49% | Upgrade
|
| Profit Margin | -39.47% | -34.66% | -44.57% | -81.00% | -257.05% | -37.50% | Upgrade
|
| Free Cash Flow Margin | -42.18% | -53.26% | -29.64% | -54.90% | -33.98% | -17.44% | Upgrade
|
| EBITDA | -5.96 | -4.31 | -4.41 | -6.1 | -0.7 | 0.2 | Upgrade
|
| EBITDA Margin | -27.96% | -22.51% | -28.49% | -63.33% | -18.19% | 5.43% | Upgrade
|
| D&A For EBITDA | 0.99 | 0.89 | 0.79 | 0.44 | 0.1 | 0.07 | Upgrade
|
| EBIT | -6.95 | -5.2 | -5.2 | -6.55 | -0.81 | 0.13 | Upgrade
|
| EBIT Margin | -32.58% | -27.16% | -33.57% | -67.95% | -20.91% | 3.49% | Upgrade
|
| Advertising Expenses | - | 0.47 | 0.26 | 0.43 | 0.24 | 0.28 | Upgrade
|
Updated Dec 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.